Targeting Nonhomologous End-Joining Through Epidermal Growth Factor Receptor Inhibition: Rationale and Strategies for Radiosensitization
To access this article, please choose from the options below
SB is supported by grants from NASA (NNA05CS97G and NNX10AE08G) and from the Cancer Prevention and Research Institute of Texas (RP100644). CN is supported by a grant from NIH (CA129364).
PII: S1053-4296(10)00036-6
doi:10.1016/j.semradonc.2010.05.002
© 2010 Elsevier Inc. All rights reserved.
